Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 450

1.

Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.

Onofrj M, Thomas A, Luciano AL, Iacono D, Di Rollo A, D'Andreamatteo G, Di Iorio A.

Clin Neuropharmacol. 2002 Jul-Aug;25(4):207-15.

PMID:
12151908
2.

Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months.

Thomas A, Iacono D, Bonanni L, D'Andreamatteo G, Onofrj M.

Clin Neuropharmacol. 2001 Jan-Feb;24(1):31-42.

PMID:
11290880
3.
4.

Long-term effects of donepezil on P300 auditory event-related potentials in patients with Alzheimer's disease.

Katada E, Sato K, Sawaki A, Dohi Y, Ueda R, Ojika K.

J Geriatr Psychiatry Neurol. 2003 Mar;16(1):39-43.

PMID:
12641372
5.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
6.

Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.

Wolfson C, Oremus M, Shukla V, Momoli F, Demers L, Perrault A, Moride Y.

Clin Ther. 2002 Jun;24(6):862-86; discussion 837. Review.

PMID:
12117079
7.

Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.

Nobili F, Vitali P, Canfora M, Girtler N, De Leo C, Mariani G, Pupi A, Rodriguez G.

Clin Neurophysiol. 2002 Aug;113(8):1241-8.

PMID:
12140003
8.

The effects of donepezil on the P300 auditory and visual cognitive evoked potentials of patients with Alzheimer's disease.

Reeves RR, Struve FA, Patrick G, Booker JG, Nave DW.

Am J Geriatr Psychiatry. 1999 Fall;7(4):349-52.

PMID:
10521169
9.

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E; Donepezil MSAD Study Investigators Group..

Neurology. 2001 Aug 28;57(4):613-20. Erratum in: Neurology 2001 Dec 11;57(11):2153.

PMID:
11524468
10.

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.

Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group..

Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69.

PMID:
15920715
11.
12.

Parallel improvement of cognitive functions and P300 latency following donepezil treatment in patients with Alzheimer's disease: a case-control study.

Chang YS, Chen HL, Hsu CY, Tang SH, Liu CK.

J Clin Neurophysiol. 2014 Feb;31(1):81-5. doi: 10.1097/01.wnp.0000436899.48243.5e.

PMID:
24492450
13.

3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy.

Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R.

Dement Geriatr Cogn Disord. 2006;21(5-6):353-63.

PMID:
16508298
14.

Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.

Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R; AWARE Study Group..

CNS Drugs. 2006;20(4):311-25. Erratum in: CNS Drugs. 2006;20(10):866.

PMID:
16599649
15.
16.

Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients.

Weiner MF, Martin-Cook K, Foster BM, Saine K, Fontaine CS, Svetlik DA.

J Clin Psychiatry. 2000 Jul;61(7):487-92.

PMID:
10937606
17.

Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.

Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.

Drugs Aging. 2008;25(2):163-74.

PMID:
18257603
18.

Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.

Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P; Donepezil MSAD Study Investigators' Group..

Curr Med Res Opin. 2002;18(6):347-54.

PMID:
12442882
19.

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Möller HJ, Rogers SL, Friedhoff LT.

Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):237-44.

PMID:
10325453
20.

Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.

Rogers SL.

Dement Geriatr Cogn Disord. 1998;9 Suppl 3:29-42. Review.

PMID:
9853200
Items per page

Supplemental Content

Support Center